STOCK TITAN

Baird Medical Sponsored and Showcased Microwave Ablation (MWA) Technology at the 7th Thyroid Disease Forum in China

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Very Positive)
Tags

Baird Medical (NASDAQ: BDMD) sponsored and participated in the 2024 7th Thyroid Disease Standardized Diagnosis and Treatment Forum in Guangzhou, China. The company showcased its advanced microwave ablation (MWA) technology for thyroid treatments, which features larger ablation zones and shorter treatment times. The event, hosted by Guangdong Provincial People's Hospital, brought together leading medical experts to discuss standardized treatment protocols for thyroid diseases. Chairwoman Haimei Wu emphasized the company's commitment to advancing solutions for thyroid disease management and improving patient outcomes globally.

Baird Medical (NASDAQ: BDMD) ha sponsorizzato e partecipato al 7° Forum sulla Diagnosi e Trattamento Standardizzato delle Malattie della Tiroide 2024 a Guangzhou, in Cina. L'azienda ha presentato la sua avanzata tecnologia di ablazione a microonde (MWA) per i trattamenti tiroidei, caratterizzata da zone di ablazione più ampie e tempi di trattamento più brevi. L'evento, ospitato dall'Ospedale Popolare Provinciale del Guangdong, ha riunito esperti medici di punta per discutere i protocolli di trattamento standardizzati per le malattie della tiroide. La presidente Haimei Wu ha sottolineato l'impegno dell'azienda nell'avanzare soluzioni per la gestione delle malattie tiroidee e nel migliorare gli esiti per i pazienti a livello globale.

Baird Medical (NASDAQ: BDMD) patrocinó y participó en el 7° Foro sobre Diagnóstico y Tratamiento Estandarizado de Enfermedades Tiroideas 2024 en Guangzhou, China. La empresa mostró su avanzada tecnología de ablación por microondas (MWA) para tratamientos de tiroides, que presenta zonas de ablación más grandes y tiempos de tratamiento más cortos. El evento, organizado por el Hospital Provincial de Guangdong, reunió a destacados expertos médicos para discutir los protocolos de tratamiento estandarizados para enfermedades tiroideas. La presidenta Haimei Wu enfatizó el compromiso de la empresa en avanzar soluciones para la gestión de enfermedades tiroideas y mejorar los resultados para los pacientes a nivel mundial.

베어드 메디컬 (NASDAQ: BDMD)는 중국 광저우에서 열린 2024년 제7회 갑상선 질환 표준화 진단 및 치료 포럼에 후원하고 참석하였습니다. 이 회사는 갑상선 치료를 위한 마이크로웨이브 절제 기술 (MWA)를 선보였으며, 이는 더 넓은 절제 범위와 짧은 치료 시간을 자랑합니다. 광둥성 인민병원이 주최한 이 행사에는 갑상선 질환에 대한 표준화된 치료 프로토콜을 논의하기 위해 저명한 의료 전문가들이 모였습니다. 회장인 하이메이 우는 갑상선 질환 관리 솔루션을 발전시키고 전 세계 환자의 결과를 개선하려는 회사의 의지를 강조했습니다.

Baird Medical (NASDAQ: BDMD) a sponsorisé et participé au 7ème Forum sur le Diagnostic et le Traitement Standardisés des Maladies Thyroïdiennes 2024 à Guangzhou, en Chine. L'entreprise a présenté sa technologie avancée d'ablation par micro-ondes (MWA) pour les traitements de la thyroïde, qui se distingue par des zones d'ablation plus larges et des temps de traitement plus courts. L'événement, organisé par l'Hôpital Provincial du Guangdong, a rassemblé des experts médicaux de premier plan pour discuter des protocoles de traitement standardisés pour les maladies de la thyroïde. La présidente Haimei Wu a souligné l'engagement de l'entreprise à faire progresser les solutions pour la gestion des maladies thyroïdiennes et à améliorer les résultats pour les patients à l'échelle mondiale.

Baird Medical (NASDAQ: BDMD) hat das 7. Forum für standardisierte Diagnose und Behandlung von Schilddrüsenerkrankungen 2024 in Guangzhou, China, gesponsert und daran teilgenommen. Das Unternehmen stellte seine fortschrittliche Mikrowellenablationstechnologie (MWA) für Schilddrüsenbehandlungen vor, die größere Ablationszonen und kürzere Behandlungszeiten bietet. Die Veranstaltung, die vom Guangdong Provincial People's Hospital ausgerichtet wurde, brachte führende medizinische Experten zusammen, um standardisierte Behandlungsprotokolle für Schilddrüsenerkrankungen zu diskutieren. Die Vorsitzende Haimei Wu betonte das Engagement des Unternehmens, Lösungen zur Verbesserung des Managements von Schilddrüsenerkrankungen und zur Verbesserung der Patientenergebnisse weltweit voranzutreiben.

Positive
  • Company's MWA technology offers improved features including larger ablation zones and shorter treatment times
  • Strategic presence and networking opportunities at a major medical forum in China
  • Strengthening market position in thyroid disease treatment sector
Negative
  • None.

NEW YORK, Nov. 25, 2024 /PRNewswire/ -- Baird Medical (NASDAQ: BDMD), a global leader in minimally invasive microwave ablation (MWA) technology, proudly sponsored and participated in the 2024 7th Thyroid Disease Standardized Diagnosis and Treatment Forum and Guangdong Pharmaceutical Society Thyroid Specialist Committee Annual Meeting, held in Guangzhou, China.

This prestigious forum, hosted by the Guangdong Provincial People's Hospital and organized by leading medical and pharmaceutical associations in Guangdong, brought together top experts and healthcare professionals to advance standardized treatment protocols for thyroid diseases. Recognized as a premier platform for academic exchange and technological innovation, the event provided an invaluable opportunity to explore the latest advancements in thyroid care.

As a sponsor, Baird Medical presented its advanced microwave ablation technology, designed to provide precise, efficient, and minimally invasive options for thyroid treatments. Attendees had the opportunity to learn about Baird's innovations, which enable larger ablation zones and shorter treatment times, setting a new standard for minimally invasive procedures.

"Baird Medical is thrilled to sponsor and contribute to this highly respected forum, which underscores our dedication to advancing cutting-edge solutions for thyroid disease management," said Haimei Wu, Chairwoman of Baird Medical. "Through our participation, we aim to support medical professionals with the tools and expertise needed to improve patient outcomes globally."

The forum also enabled Baird Medical to engage in meaningful discussions with leading experts, enhance collaborations, and highlight its commitment to expanding the reach of innovative treatments both within China and globally. Sponsoring this influential event further solidifies Baird Medical's position as a leader in the field of minimally invasive treatments for thyroid diseases.

About Baird Medical
Baird Medical is a leading provider of minimally invasive microwave ablation (MWA) technology, offering advanced treatment solutions for conditions such as thyroid nodules, breast disease, uterine fibroids, and liver cancer. A publicly traded company on NASDAQ, Baird Medical is dedicated to enhancing patient care through precision, efficiency, and safety in its innovative medical devices. For more information, please visit https://bairdmed.com/

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/baird-medical-sponsored-and-showcased-microwave-ablation-mwa-technology-at-the-7th-thyroid-disease-forum-in-china-302315066.html

SOURCE BDMD

FAQ

What technology did Baird Medical (BDMD) showcase at the 2024 Thyroid Disease Forum in China?

Baird Medical showcased its microwave ablation (MWA) technology, featuring larger ablation zones and shorter treatment times for thyroid treatments.

Where was the 7th Thyroid Disease Forum that Baird Medical (BDMD) sponsored in 2024?

The forum was held in Guangzhou, China, hosted by the Guangdong Provincial People's Hospital.

What are the key features of Baird Medical's (BDMD) microwave ablation technology?

The technology offers larger ablation zones and shorter treatment times, providing precise and minimally invasive options for thyroid treatments.

Baird Medical Investment Holdings Ltd Ordinary Share

NASDAQ:BDMD

BDMD Rankings

BDMD Latest News

BDMD Stock Data

68.46M
30.03M
22.16%
0.99%
0.07%
Medical Devices
Healthcare
Link
United States of America
Guangzhou